Close
More
 
 

Join Now

It's Free - Always

First Name
 
Last Name
 
Zip/Postal Code
 
Country of Practice
 
 
 
Specialty
Email
 
Password
 
Confirm Password
 
Terms
I have read and agree to the Participant Terms and Conditions
 
 
 

is already registered on QuantiaMD

Is this you? Enter your password to continue.
The password you entered is incorrect. Please try again or choose a different option.
Create new password? Click here and instructions on creating a new password will be sent to the above email address.
Need more help? Contact Member Support
 
 

is already registered on QuantiaMD

 
 
Instructions to create a new password have been sent to the following email address:

For further assistance, please Contact Member Support
Thank you for registering on QuantiaMD.

Create new password?

Please enter your email address below, and we will send you a link to create a new password.

Submit

Create new password?

Email address:
 
Password
 
Confirm Password
 
Submit
Earn this Certificate
0%
0 out of 5 completed
Medical Management of Diabetes: A 2016 Update

Your patient is one of the majority of US patients with diabetes who are not able to achieve their target A1c goals. What do you do? Dr. Neil Skolnik and colleagues offer an overview of your treatment options with an emphasis on newer medications for diabetes. They will discuss barriers to achieving A1c goals, criteria for individualizing treatment for each patient, and how to decide which medication to choose next when your patients are not reaching their target. They will address the ADA’s evaluation of several drug classes’ efficacy, hypoglycemia risk, weight considerations, side effects, and cost, so that you are armed with a comprehensive understanding of how to best treat each of your patients.

Neil Skolnik, MD
Professor of Family and Community Medicine, Temple University School of Medicine, Associate Director, Family Medicine Residency Program, Abington Jefferson Health
Start the next presentation
You've completed 0 out of 5 presentations
 
Expert Presentations
Neil Skolnik, MD
Professor of Family and Community Medicine, Temple University School of Medicine, Associate Director, Family Medicine Residency Program, Abington Jefferson Health
(107)
15 Comments
Andrew S. Rhinehart, MD, FACP, FACE, CDE, BC-ADM, CDTC
Chief Medical Officer, Glytec
(464)
206 Comments
Eric Johnson, MD
Associate Professor, University of North Dakota School of Medicine and Health Sciences, Assistant Medical Director, Altru Diabetes Center, Grand Forks, ND
(1,176)
182 Comments
Jay H. Shubrook, DO, FACOFP, FAAFP
Professor, Touro University California College of Osteopathic Medicine, Vallejo, CA
(485)
196 Comments, last 8 days ago
Jim Chamberlain, MD
Medical Director for Diabetes Services, St. Mark’s Hospital and St. Mark’s Diabetes Center, Salt Lake City, Utah
(949)
185 Comments
Latest Comments
"Any evidence to support concurrent use of a GLP-1 agonist and a DPP-4 inh?  Synergistic effect/potentiating effect? Thanks"
Ritesh Patil, MD, MPH
PRIVATE PRACTICE, Dr. Ritesh Patil, MD
196 Comments, last 8 days ago
"what is your approach in prescribing pioglitazone and the risk of bladder cancer? I understand that the fda recently released another warning about this issue"
Keith Suarez, MD
Baylor Scott and White
15 Comments
 
Terms | Privacy | FAQ | support@quantiamd.com | 1-800-773-4162
©2016 Quantia, a wholly owned subsidiary of Aptus Health, Inc.
 
Version 2.13.97.81